Agate Pass Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,500
| Closed | -$213K | – | 109 |
|
|
2025
Q1 | $213K | Buy |
+3,500
| New | +$213K | 0.09% | 106 |
|
|
2024
Q2 | – | Sell |
-4,000
| Closed | -$217K | – | 95 |
|
|
2024
Q1 | $217K | Sell |
4,000
-200
| -5% | -$10.8K | 0.12% | 93 |
|
|
2023
Q4 | $216K | Hold |
4,200
| – | – | 0.12% | 93 |
|
|
2023
Q3 | $244K | Sell |
4,200
-524
| -11% | -$30.4K | 0.17% | 78 |
|
|
2023
Q2 | $302K | Hold |
4,724
| – | – | 0.18% | 81 |
|
|
2023
Q1 | $327K | Hold |
4,724
| – | – | 0.21% | 83 |
|
|
2022
Q4 | $340K | Hold |
4,724
| – | – | 0.24% | 80 |
|
|
2022
Q3 | $336K | Hold |
4,724
| – | – | 0.26% | 79 |
|
|
2022
Q2 | $364K | Hold |
4,724
| – | – | 0.26% | 79 |
|
|
2022
Q1 | $345K | Hold |
4,724
| – | – | 0.22% | 80 |
|
|
2021
Q4 | $295K | Buy |
+4,724
| New | +$295K | 0.18% | 87 |
|